Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
 
No Matching Results
Advanced search
or
Market: Market:

Chromadex Corp CS (CDXC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Alerts
Watch
Help
Go To:
ChromaDex to Present at the 20th Annual B. Riley FBR Investor Conference GlobeNewswire - Wed May 15, 3:02PM CDT
CMTX - Wed May 15, 3:02PM CDT

ChromaDex Corp. (NASDAQ:CDXC) announced today that its Chief Executive Officer, Rob Fried, and Chief Financial Officer, Kevin Farr, will present at the 20 Annual B. Riley FBR Investor Conference at the...

CDXC : 4.50 (-1.32%)
ChromaDex (CDXC) Reports Q1 Loss, Tops Revenue Estimates Zacks Equity Research - Zacks Investment Research - Thu May 9, 5:45PM CDT
Zacks Equity Research - ZACKS - Thu May 9, 5:45PM CDT

ChromaDex (CDXC) delivered earnings and revenue surprises of 0.00% and 2.58%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

CDXC : 4.50 (-1.32%)
ChromaDex Corporation Reports First Quarter 2019 Financial Results GlobeNewswire - Thu May 9, 3:03PM CDT
CMTX - Thu May 9, 3:03PM CDT

- First Quarter 2019 Net Revenues Increased by 53% to $10.0 Million -

CDXC : 4.50 (-1.32%)
ChromaDex Announces $10 Million Issuance of Convertible Notes GlobeNewswire - Thu May 9, 7:21AM CDT
CMTX - Thu May 9, 7:21AM CDT

ChromaDex Corp. (NASDAQ:CDXC) announced today that it has entered into a note purchase agreement for the sale of $10.0 million of convertible notes in a private placement. The transaction was led by international...

CDXC : 4.50 (-1.32%)
ChromaDex to Report First Quarter 2019 Financial Results on Thursday, May 9, 2019 GlobeNewswire - Thu May 2, 5:30AM CDT
CMTX - Thu May 2, 5:30AM CDT

ChromaDex Corp. (NASDAQ:CDXC) announced that it will hold a conference call on Thurs., May 9, 2019 at 4:30 p.m. Eastern time to discuss its financial results for the first quarter ended March 31, 2019....

CDXC : 4.50 (-1.32%)
ChromaDex Furthers TRU NIAGEN(R) Global Expansion in Canada with WELL Health Technologies GlobeNewswire - Wed Apr 24, 5:30AM CDT
CMTX - Wed Apr 24, 5:30AM CDT

ChromaDex Corp. (NASDAQ:CDXC) announced today a new distribution partnership for TRU NIAGEN(R) with Vancouver-based WELL Health Technologies Corp. (TSX.V: WELL) who intends on distributing TRU NIAGEN(R)...

CDXC : 4.50 (-1.32%)
WELL.VN : 0.720 (+7.46%)
ChromaDex Drives Global Expansion Strategy for TRU NIAGEN(R) with Specialty Retail Launch and Expanded eCommerce Distribution in Canada GlobeNewswire - Mon Apr 15, 5:30AM CDT
CMTX - Mon Apr 15, 5:30AM CDT

ChromaDex Corp. (NASDAQ:CDXC) announced today the latest milestone in its global expansion strategy for TRU NIAGEN, with a strategic deal with specialty retailer Showcase in Toronto, Canada. Tru Niagen...

CDXC : 4.50 (-1.32%)
New Study Deepens Research Into the Potential Cardiovascular Health Benefits of Supplementation with Nicotinamide Riboside (NR) BusinessWire - Tue Apr 9, 5:30AM CDT
CMTX - Tue Apr 9, 5:30AM CDT

ChromaDex Corp. (NASDAQ:CDXC) today reported that results of a new preclinical study showed that supplementation with the unique B3 vitamin nicotinamide riboside (NR, or Niagen(R))...

CDXC : 4.50 (-1.32%)
Dr. Charles Brenner, Discoverer of Nutrient Nicotinamide Riboside as a Vitamin, Announced as Speaker at Upgrade XP's Sixth Annual Biohacking Conference GlobeNewswire - Wed Apr 3, 5:29AM CDT
CMTX - Wed Apr 3, 5:29AM CDT

ChromaDex Corp. (NASDAQ:CDXC) announced today its Chief Scientific Advisor, Dr. Charles Brenner, the world's foremost authority on NAD metabolism and discoverer of nicotinamide riboside as a vitamin, will...

CDXC : 4.50 (-1.32%)
Consolidated Research: 2019 Summary Expectations for Vishay Intertechnology, Belmond, Silicon Motion Technology, Ardmore Shipping, Northwest Pipe, and ChromaDex -- Fundamental Analysis, Key Performance Indications GlobeNewswire - Mon Apr 1, 7:39AM CDT
CMTX - Mon Apr 1, 7:39AM CDT

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Vishay Intertechnology, Inc. (NYSE:VSH),...

ASC : 7.71 (+2.39%)
CDXC : 4.50 (-1.32%)
NWPX : 25.16 (+0.20%)
BEL : 24.99 (unch)
VSH : 16.12 (-1.95%)
SIMO : 38.36 (-5.52%)
Exactus Appoints Troy Rhonemus to Advisory Board GlobeNewswire - Mon Apr 1, 5:29AM CDT
CMTX - Mon Apr 1, 5:29AM CDT

Exactus Inc. (OTCQB: EXDI / OTCQB: EXDID), a healthcare company pursuing opportunities in Hemp derived, Cannabidiol (CBD) products, is pleased to announce the appointment of Troy Rhonemus to the Advisory...

CDXC : 4.50 (-1.32%)
EXDI : 0.9200 (+21.05%)
ChromaDex to Present at the 31st Annual ROTH Conference GlobeNewswire - Mon Mar 11, 3:00PM CDT
CMTX - Mon Mar 11, 3:00PM CDT

ChromaDex Corp. (NASDAQ:CDXC) announced today that its Chief Executive Officer, Rob Fried, Chairman and Co-Founder, Frank Jaksch, and Chief Financial Officer, Kevin Farr, will present at the 31 annual...

CDXC : 4.50 (-1.32%)
ChromaDex Corporation Reports 2018 Financial Results GlobeNewswire - Thu Mar 7, 3:00PM CST
CMTX - Thu Mar 7, 3:00PM CST

- Full Year 2018 Net Revenues Increased by 49% to $31.6 Million and Fourth Quarter 2018 Net Revenues Increased by 20% to $9.1 Million -

CDXC : 4.50 (-1.32%)
ChromaDex to Present at the 39th Annual Cowen Health Care Conference GlobeNewswire - Fri Mar 1, 5:29AM CST
CMTX - Fri Mar 1, 5:29AM CST

ChromaDex Corp. (NASDAQ:CDXC) announced today that its Chief Executive Officer, Rob Fried, and Chief Financial Officer, Kevin Farr, will present at the 39 Annual Cowen Heath Care Conference at the Boston...

CDXC : 4.50 (-1.32%)
ChromaDex to Report Fourth Quarter 2018 Financial Results on Thursday, March 7, 2019 GlobeNewswire - Thu Feb 28, 5:29AM CST
CMTX - Thu Feb 28, 5:29AM CST

ChromaDex Corp. (NASDAQ:CDXC) announced that it will hold a conference call on Thurs., Mar. 7, 2019 at 4:30 p.m. Eastern time to discuss its financial results for the fourth quarter ended December 31,...

CDXC : 4.50 (-1.32%)
New Study Shows Supplementation with Nicotinamide Riboside (NR) During Breastfeeding Yields Measurable, Lasting Benefits to Mothers and Offspring in Animal Model GlobeNewswire - Wed Jan 23, 5:31AM CST
CMTX - Wed Jan 23, 5:31AM CST

ChromaDex Corp. (NASDAQ:CDXC) today reported that results of a first-of-a-kind preclinical study on lactation have shown that supplementation with the unique B3 vitamin nicotinamide riboside (NR, or Niagen)...

CDXC : 4.50 (-1.32%)
ChromaDex Prepared to Proceed with Patent Infringement Action Against Elysium Health GlobeNewswire - Tue Jan 22, 3:05PM CST
CMTX - Tue Jan 22, 3:05PM CST

ChromaDex Corp. (NASDAQ:CDXC) today reported the rejection of Elysium Health Inc.'s challenge to Claim 2 of U.S. Patent No. 8,383,086 ("the '086 patent") by the Patent Trial and Appeal Board (PTAB) of...

CDXC : 4.50 (-1.32%)

Van Meerten Stock Picks

Aaon - Pick of the Day
My Stock Pick of the Day is the HVAC company AAON (AAON).
Tue Apr 23, 12:42PM CDT
AAON +0.41
See More
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
Reserve Your Spot